Abstract
Breast phyllodes tumors are rare neoplasms which present challenges for histological classification. Microscopic features are not always predictive of clinical behavior, and scarce data exist on the prognostic role of biological markers. Our study evaluated a series of 145 phyllodes tumors diagnosed at the Department of Pathology, Singapore General Hospital between 2006 and 2009, incorporating 91 (62.8%) benign, 40 (27.6%) borderline, and 14 (9.7%) malignant phyllodes tumors. Antibodies to keratin 15 (KRT15), transcobalamin I (TCN1), and homeobox gene Hox-B13 (HOXB13) were applied to sections cut from tissue microarray blocks. KRT15 and TCN1 positivity was defined when there was reactivity of 1% or more stromal cells, while HOXB13 positivity was defined using a H-score of 100 and above. Positive immunohistochemical expression for KRT15, TCN1, and HOXB13 was seen in 21 (14.5%), 96 (66.2%), and 66 (45.5%) of tumors, respectively. Stromal expression of KRT15, TCN1, and HOXB13 was significantly correlated with tumor grade (P < 0.001, P < 0.001, P = 0.012), stromal hypercellularity (P = 0.005, P < 0.001, P = 0.023), mitotic activity (P < 0.001), and microscopic borders (P = 0.006, P < 0.001, P = 0.011). Co-expression of TCN1 and HOXB13 was seen in 21 of 91 (23.1%) benign, 18 of 40 (45.0%) borderline, and 11 of 14 (78.6%) malignant tumors, suggesting that the dual-marker panels of TCN1 and HOXB13 might be helpful in classifying borderline and malignant tumors. Although expression of TCN1 alone was present in all malignant and 34 of 40 (85.0%) borderline tumors, a combined panel with HOXB13 excluded some benign cases and was a better discriminant for a significant proportion of borderline and malignant tumors.
Similar content being viewed by others
References
Chaney AW, Pollack A, Mcneese MD et al (2000) Primary treatment of cytosarcoma phyllodes of the breast. Cancer 89:1502–1511
Jacklin RK, Ridgway PF, Ziprin P et al (2006) Optimizing preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol 59:454–459
Tan PH, Jayabaskar T, Yip G et al (2005) p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod Pathol 18:1527–1534
Jara-Lazaro AR, Akhilesh M, Thike AA et al (2010) Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms. Histopathology 57:220–232
Lee AHS (2008) Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology 52:45–57
Karim RZ, Gerega SK, Yang YH et al (2010) p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours. Histopathology 56(7):868–875
Tan PH, Jayabaskar T, Chuah KL et al (2005) Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol 123:529–540
Pietruszka M, Barnes L (1978) Cystosarcoma phyllodes. A clinicopathologic analysis of 42 cases. Cancer 41:1974–1983
Waseem A, Dogan B, Tidman N et al (1999) Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Investig Dermatol 112:363–369
Celis JE, Gromova I, Cabezón T et al (2007) Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15D progenitor/amplified cells and pre-malignant lesions and invasive disease. Mol Oncol 1:321–349
Franzén B, Linder S, Alaiya AA et al (1996) Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. Br J Cancer 73:1632–1638
Han J, Kioi M, Chu WS et al (2009) Identification of potential therapeutic targets in human head and neck squamous cell carcinoma. Head Neck Oncol 1:27
Whittock NV, Eady RAJ, McGrath JA (2000) Genomic organization and amplification of the human keratin 15 and keratin 19 genes. Biochem Biophys Res Commun 267:462–465
Waibel R, Treichler H, Schaefer N et al (2008) New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Res 68:2904–2911
Carmel R (1975) Extreme elevation of serum transcobalamin I in patients with metastatic cancer. N Engl J Med 292:282–284
Mishra Pravin J, Mishra Prasun J, Humeniuk R et al (2008) Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68:4331–4339
Jerevall PL, Jansson A, Fornander T et al (2010) Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer. Breast Cancer Res 12:R53
Svingen T, Tonissen K (2003) Altered HOX gene expression in human skin and breast cancer cells. Cancer Biol Ther 2(4):518–523
Edwards S, Campbell C, Flohr P et al (2005) Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer 92:376–381
Ang MK, Ooi AS, Thike AA et al (2010) Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression. Breast Cancer Res Treat. doi:10.1007/s10549-010-1204-5
Thike AA, Chng MJ, Fook-Chong S, Tan PH (2001) Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology 33:21–25
Allred DC, Harvey JM, Berardo M et al (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155–168
Wilson CL, Miller CJ (2005) Simpleaffy: a BioConductor package for Affymetrix quality control and data analysis. Bioinformatics 21:3683–3685
Gautier L, Cope LM, Bolstad BM, Irizarry RA (2004) Affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20:307–315
Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (eds) Bioinformatics and computational biology solutions using R and bioconductor. Springer, New York, pp 397–420
Folgueira MAAK, Brentani H, Katayama MLH et al (2006) Gene expression profiling of clinical stages II and III breast cancer. Braz J Med Biol Res 39:1101–1113
Dunne B, Lee AHS, Pinder SE et al (2003) An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum Pathol 34:1009–1015
Ogawa K, Kudo H, Kim YC, Nakashima Y, Ohshio G, Yamabe H (1988) Expression of vitamin B12 R-binder in breast tumors. An immunohistochemical study. Arch Pathol Lab Med 112:1117–1120
Cantile M, Pettinato G, Procino A et al (2003) In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer 39:257–264
Acknowledgments
This study is supported by a grant from the Singapore Cancer Syndicate MS04R.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chong, L.YZ., Cheok, P.Y., Tan, WJ. et al. Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification. Breast Cancer Res Treat 132, 143–151 (2012). https://doi.org/10.1007/s10549-011-1555-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1555-6